EGFR and neoplasm: Studies have proven that the mitogen-activated protein kinase (MAPK), the phosphoinositide 3-kinase (PI3K)/Akt, and the epidermal growth factor receptor (EGFR) signal transduction cascades function abnormally in most tumor cases and therefore, they became key targets for targeted therapy-mediated cell death [29].